eye to eye with Abbas Hussain, President of Emerging Markets, GlaxoSmithKline

Authored by Abbas Hussain, Senior Partner, C-Bridge Capital

In collaboration with Accenture, Criticaleye conducted a series of interviews with business leaders discussing the rise of the multi-polar world and what that means for business.

In this 5-minute excerpt from one of those interviews, we posed our questions to
Abbas Hussain, President of Emerging Markets, GlaxoSmithKline.

Share this with your Community




Click here to download this insight

DOWNLOAD INSIGHT



Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.

Click here to download this insight
Driving Growth and Value as C...

Ithaca Energy has developed into a major player in the North Sea oil industry during Iain Lewis’ three years as CFO. In this interview with Criticaleye, he discusses the company’s IPO in 2022, its M&A st...

Click here to download this insight
Reaching New Heights at Guoco...

After four years in the Group CFO role at one of Singapore’s most prominent real estate developers, GuocoLand Group, Andrew Chew talks to Jacob Ambrose Willson about stepping up from regional CFO to Group, managin...

Click here to download this insight
Inside the Take-private at Pr...

After a whirlwind journey from the NYSE to private ownership, PropertyGuru CFO Joe Dische reflects on making the hard calls. In this interview with Criticaleye Senior Editor Bridgette Hall, he discusses public vs privat...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 320




Drax Group plc Lightsource bp London Stock Exchange Group Google E.ON UK NatWest Group Eightfold AI Hitachi Solutions Worldpay FTSE Women Leaders Review NATS Salesforce Rolls-Royce Palo Alto Networks Legal & General British Land IBM Consulting Workday AlixPartners Aldermore Group GlaxoSmithKline plc Accenture Concentrix